|
Peptide Therapeutic for Immune Response Activation against Metastatic Triple Negative Breast Cancer
This invention provides compositions and methods for treating triple negative breast cancer using peptides or peptide mimics that bind to epidermal growth factor receptor (EGFR) to block EGFR nuclear translocation. This mode of action alters EGFR-dependent gene transcription, induces the loss of cancer cell survival and migratory capacity, and...
Published: 3/12/2024
|
Inventor(s): Joyce Schroeder, Angelica Escoto, Benjamin Atwell
Keywords(s):
Category(s): Technology Classifications > Healthcare Portfolios > Oncology, Technology Classifications > Life Sciences > Therapeutics
|
